Semaglutide is suitable for individuals with a BMI of 27 or higher, especially those with weight-related health conditions such as type 2 diabetes, hypertension, or high cholesterol
This hormone regulates blood sugar and makes you feel full, potentially leading to weight loss
Patient education about expected side effects, their typical time course, and management strategies significantly improves treatment adherence and outcomes
Unleash the Benefits of Weekly Dosing Supported by extensive clinical research
This article was originally published on WBUR.org
In advance of availability, Novo Nordisk is actively sharing clear, timely information with patients, caregivers, and healthcare professionals about the name change from Rybelsus to the Ozempic pill, its dosage strengths, and what people can expect at the pharmacy in May